Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Rookus
Matti A
MA
Brohet
Richard
R
van Leeuwen
Flora E
FE
D001943:Breast Neoplasms / Q000139:chemically induced* / Q000235:genetics; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006579:Heterozygote; D006801:Humans; D009154:Mutation; D015588:Observer Variation; D016017:Odds Ratio; D018579:Patient Selection; D012107:Research Design; D012307:Risk Factors; D016019:Survival Analysis
D003278:Contraceptives, Oral, Hormonal